Opthea downgraded to Market Perform from Outperform at Leerink
PremiumThe FlyOpthea downgraded to Market Perform from Outperform at Leerink
12d ago
Opthea cut to Market Perform at Leerink on failed sozinibercept trial
Premium
The Fly
Opthea cut to Market Perform at Leerink on failed sozinibercept trial
12d ago
Opthea double downgraded to Underperform from Buy at Jefferies
Premium
The Fly
Opthea double downgraded to Underperform from Buy at Jefferies
12d ago
Opthea Limited: Hold Rating Amid Phase 3 Trial Failure and Financial Uncertainty
PremiumRatingsOpthea Limited: Hold Rating Amid Phase 3 Trial Failure and Financial Uncertainty
13d ago
Opthea COAST trial misses primary endpoint, enters talks with DFA Investors
Premium
The Fly
Opthea COAST trial misses primary endpoint, enters talks with DFA Investors
14d ago
Opthea Limited Suspends Trading Pending Clinical Trial Results
Premium
Company Announcements
Opthea Limited Suspends Trading Pending Clinical Trial Results
19d ago
Opthea Limited Announces Quotation of New Securities on ASX
PremiumCompany AnnouncementsOpthea Limited Announces Quotation of New Securities on ASX
24d ago
Opthea Limited Announces New Securities Quotation on ASX
Premium
Company Announcements
Opthea Limited Announces New Securities Quotation on ASX
27d ago
Opthea Limited Announces New Securities Quotation on ASX
Premium
Company Announcements
Opthea Limited Announces New Securities Quotation on ASX
27d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100